Interestingly, the phenotype of transgenic mice lacking the INSR in osteoblasts, with decreased circulating OC, decreased bone formation and insulin resistance [9], are similar to the clinical features characterizing CS patients [35], [36]. The gene discussed is INSR; the disease is Insulin resistance.